Anaptysbio (ANAB) Preferred Dividend Payments (2016)

Anaptysbio (ANAB) posted Preferred Dividend Payments of $2.1 million for Q2 2016.

Anaptysbio (ANAB) Preferred Dividend Payments (2016) Analysis & Trends

Anaptysbio's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $2.1 million for Q2 2016.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $2.1 million in Q2 2016, while the trailing twelve-month figure through Sep 2017 was $2.1 million (changed N/A YoY) and the FY2024 annual result came in at -$82000.0, down 46.43% from the prior year.
Preferred Dividend Payments was $2.1 million for Q2 2016 at Anaptysbio.
Across five years, Preferred Dividend Payments topped out at $2.1 million in Q2 2016 and bottomed at $2.1 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Anaptysbio	1.55 Bn	1.27 Bn	-	-

Download Data

Date	Value
Jun 30, 2016	2.14 Mn